EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Столичная издательская компания
2016-01-01
|
| Collection: | Рациональная фармакотерапия в кардиологии |
| Sujets: | |
| Accès en ligne: | https://www.rpcardio.online/jour/article/view/820 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|